{
    "nct_id": "NCT06050265",
    "official_title": "Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome",
    "inclusion_criteria": "For aim 1:\n\n* Aged 18-45\n* Female sex\n* Agree to wear a CGM for 10 days\n* Have access to an apple or android smart phone for CGM monitoring\n* Are able to be characterized as PCOS or non-PCOS using the 2003 Rotterdam criteria for PCOS of 2 or more of the following: 1) biochemical or clinical hyperandrogenism, 2) polycystic ovarian morphology on transvaginal ultrasound, and/or 3) oligo-amenorrhea\n\nFor aim 2:\n\n* All of the inclusion criteria for aim 1\n* Meet 2003 Rotterdam criteria for PCOS as above\n* Evidence of baseline glycemic dysregulation including any of the following: 1) elevated fasting glucose (100-125 mg/dL), 2) elevated 2 hour glucose (140-200 mg/dL), 3) elevated fasting insulin (>10 mIU/mL), 4) elevated 2 hour insulin (>40 mIU/mL), 5) elevated Hgba1c (5.7- 6.4)\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 45 Years",
    "exclusion_criteria": "For both aims 1 and 2:\n\n* Use of metformin or other anti-diabetic agents\n* Diagnosis of type I or II diabetes mellitus (including those found to have fasting glucose >126, 2 hour glucose >200, Hgba1c >6.5)\n* Prior or current use of CGM",
    "miscellaneous_criteria": ""
}